Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30.8M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
4.33M
-
Shares change
-
+319K
-
Total reported value, excl. options
-
$56.1M
-
Value change
-
+$4.05M
-
Number of buys
-
39
-
Number of sells
-
-11
-
Price
-
$12.95
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2021
67 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2021.
XBiotech Inc. - Common Shares, no par value (XBIT) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.33M shares
of 30.8M outstanding shares and own 14.09% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.22M shares), VANGUARD GROUP INC (885K shares), STATE STREET CORP (436K shares), GEODE CAPITAL MANAGEMENT, LLC (306K shares), NORTHERN TRUST CORP (251K shares), WELLS FARGO & COMPANY/MN (147K shares), CREDIT SUISSE AG/ (135K shares), Nuveen Asset Management, LLC (70.4K shares), Bank of New York Mellon Corp (58.9K shares), and AQR CAPITAL MANAGEMENT LLC (57.4K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.